Speaker illustration

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)

Member of:

European Society of Cardiology

Dr. Lincoff is Vice Chairman for Research of the Department of Cardiovascular Medicine and an interventional cardiologist at the Cleveland Clinic. He is the Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), an academic research organization which plans and manages multicenter clinical trials. His research focuses on leadership of large scale trials testing therapies to reduce complications of coronary artery disease or reduce progression of atherosclerosis. He also supervises clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research of the Lerner Research Institute. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Lincoff has authored or coauthored over 400 peer-reviewed articles and presented over 400 lectures throughout the world. He is a consultant for the United States FDA.

Targeting cardiovascular risk factors with GLP-1 RAs in people with obesity

Event: ESC Congress 2022

Topic: Obesity and Diabetes

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb